2009 Annual Meeting | Poster Session 07

Date Thursday 04/30/09

Time 07:00 AM - 10:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Sleep, Aging and Dementia, Anterior Horn, Behavioral Neurology, Child Neurology/Developmental Neurobiology, Epilepsy, MS and Related Diseases, Peripheral Nerve

CME Available No CME available

Event Timeline
07:00 AM - 08:30 AM		Break
07:00 AM - 10:00 AM	Abstract	002 - Sudden Unexpected Near Death in Epilepsy (SUNDEP): Malignant Ventricular Arrhythmia from a Partial Seizure
07:00 AM - 10:00 AM	Abstract	003 - Levetiracetam Extended Release: Population Dose-Response Modeling in Adults with Partial-Onset Seizures
07:00 AM - 10:00 AM	Abstract	004 - Meta-Analysis of Levetiracetam Used in Status Epilepticus
07:00 AM - 10:00 AM	Abstract	005 - Patient Abilities and Techniques Used for Seizure Self-Termination
07:00 AM - 10:00 AM	Abstract	006 - Carbamazepine and Atherosclerosis: Is There Any Link?
07:00 AM - 10:00 AM	Abstract	007 - Visual Field Defects after Transylvian Selective Amygdalohippocampectomy
07:00 AM - 10:00 AM	Abstract	008 - Novel Neuroprotective Drugs Against Experimentally Induced Status Epilepticus
07:00 AM - 10:00 AM	Abstract	009 - Clinical Characteristics of Alcohol Related Seizures
07:00 AM - 10:00 AM	Abstract	010 - Ketogenic Diet Treatment of Intractable Epilepsy
07:00 AM - 10:00 AM	Abstract	011 - Effect of Levetiracetam on Testosterone Levels in Male Patients
07:00 AM - 10:00 AM	Abstract	012 - Comorbidities in Patients with Psychogenic Nonepileptic Seizures
07:00 AM - 10:00 AM	Abstract	013 - A Profile of Adolescent-Onset Epilepsy
07:00 AM - 10:00 AM	Abstract	014 - Relationship between Dysautonomia, Clinical Features and Cognitive Dysfunction in Dementia with Lewy Bodies
07:00 AM - 10:00 AM	Abstract	015 - Feasibility, Reliability, and Minimal Detectable Change for Maximal Exercise Testing in Mild Alzheimer Disease
07:00 AM - 10:00 AM	Abstract	017 - Association Study of Serum Heme Oxigenase-1 Levels with Alzheimer's and Parkinson's Diseases
07:00 AM - 10:00 AM	Abstract	018 - Memantine Discontinuation Due to Non-Medical Reasons Is Associated with a Subsequent Decline in Patients' Health Status in Nursing Home Residents with Alzheimer's Disease
07:00 AM - 10:00 AM	Abstract	019 - Idiopathic Parkinson's-Like [alpha]-Synucleopathy in TDP-43-Negative FTLD-U with Basophilic Inclusions
07:00 AM - 10:00 AM	Abstract	020 - 3-n-Butylphthalide Improves Cognitive Deficits of SAMP8 Mice
07:00 AM - 10:00 AM	Abstract	021 - MCP-1 A-2518G Polymorphism: Effect on Susceptibility for Frontotemporal Lobar Degeneration and on Cerebrospinal Fluid MCP-1 Level
07:00 AM - 10:00 AM	Abstract	022 - Relevance of CSF Levels of Secreted Amyloid-b Precursor Protein (APP) and Amyloid-[beta] Peptides (A[beta]) in NPH to Alzheimer's Disease
07:00 AM - 10:00 AM	Abstract	023 - The Contribution of Apolipoprotein E Alleles on Cognitive Performance and Behavioral Changes in Alzheimer's Disease
07:00 AM - 10:00 AM	Abstract	024 - Depression and Somatic Symptoms Determine Quality of Life in Nonepileptic Seizures
07:00 AM - 10:00 AM	Abstract	025 - ERP Abnormalities of Auditory Attention in Fragile X-Associated Tremor/Ataxia Syndrome
07:00 AM - 10:00 AM	Abstract	026 - Neural Correlates of Successful Attention and Executive Functions Training in MS: An fMRI Study
07:00 AM - 10:00 AM	Abstract	027 - Distractibility and Alzheimer Disease: The "Neglected" Phenomenon
07:00 AM - 10:00 AM	Abstract	028 - A Restless Dementia Responsive to Carbidopa/Levodopa: A Case Study
07:00 AM - 10:00 AM	Abstract	029 - Functional MRI of Dynamic 3D Visual Object Recognition
07:00 AM - 10:00 AM	Abstract	030 - Prism Adaptation and Learning Curves in Spatial Neglect
07:00 AM - 10:00 AM	Abstract	031 - Dopaminergic Modulation of Degenerative Spatial Neglect Phenomena
07:00 AM - 10:00 AM	Abstract	032 - MEANING: Musical Emotion and Affect Naming In NeurodeGeneration - A Pilot Investigation
07:00 AM - 10:00 AM	Abstract	033 - Effect of Prism Adaptation on "Aiming" Spatial Bias and Functional Abilities
07:00 AM - 10:00 AM	Abstract	034 - Real Time Functional MRI: Next Generational fMRI
07:00 AM - 10:00 AM	Abstract	035 - Genetic Association Studies of Immune Genes in Autism
07:00 AM - 10:00 AM	Abstract	036 - Magnetic Source Imaging (MSI) Activation of the Mesial Temporal Lobe: Relationship to Wada Memory Performance
07:00 AM - 10:00 AM	Abstract	037 - Cognitive and Functional Consequences of Chronic Cerebellar Injury
07:00 AM - 10:00 AM	Abstract	038 - Complex Regional Pain Syndrome - A Cluster Analysis of Neuropsychological Deficits
07:00 AM - 10:00 AM	Abstract	039 - Neuro-Anatomical Correlates of Visual Memory in Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	040 - Behavioral and Cortical Activation Patterns in Hemianopia
07:00 AM - 10:00 AM	Abstract	041 - Age-Related Differences in Efficiency of Working Memory Processing among High vs. Low Performers: When Is Less More?
07:00 AM - 10:00 AM	Abstract	042 - Putaminal Volumetrics in Frontotemporal Lobar Degeneration: Manual Tracing Showing Differential Volumes in Subtypes of FTLD
07:00 AM - 10:00 AM	Abstract	043 - Noradrenergic Effects on Functional Connectivity in Autism Spectrum Disorder
07:00 AM - 10:00 AM	Abstract	044 - Motor Cortex Reward Signaling in Parkinson's Disease
07:00 AM - 10:00 AM	Abstract	045 - Altered Auditory Feedback in Stuttering: Preliminary Studies
07:00 AM - 10:00 AM	Abstract	046 - Creativity in Parkinson Disease as a Function of Right Versus Left Hemibody Onset
07:00 AM - 10:00 AM	Abstract	047 - Decreased Frequency of Severe Arithmetic Learning Disability in Girls with Turner Syndrome Treated with Oxandrolone Versus Placebo
07:00 AM - 10:00 AM	Abstract	048 - The Effect of Ejection Fraction and Age on Memory Functioning in Older Adults with Heart Failure
07:00 AM - 10:00 AM	Abstract	049 - Effects of Adjunctive Armodafinil on Patients with Schizophrenia
07:00 AM - 10:00 AM	Abstract	050 - Seronegative Non-Paraneoplastic Limbic Encephalitis: New Evidence of Autoimmune Pathogenesis
07:00 AM - 10:00 AM	Abstract	051 - Gabapentin Enacarbil Improves Sleep in Subjects with Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	052 - Gabapentin Enacarbil Improves Mood, Quality of Life (QOL) and Functioning in Subjects with Primary Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	053 - Gabapentin Enacarbil Relieves the Pain Associated with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	054 - A Randomized, Double-Blind, Placebo-Controlled Study To Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	055 - The Maintenance of Efficacy and Long-Term Tolerability of Gabapentin Enacarbil Compared with Placebo in Subjects with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	056 - Efficacy and Safety of Pramipexole for Restless Legs Syndrome: A 26 Week Randomized, Placebo-Controlled Clinical Trial in the European Union
07:00 AM - 10:00 AM	Abstract	057 - Efficacy and Tolerability of Rotigotine in the Treatment of Patients with Most Severe RLS and Augmentation - A 12 Months Clinical Survey
07:00 AM - 10:00 AM	Abstract	058 - Augmentation in the Therapy of the Restless Legs Syndrome with Transdermal Rotigotine - A Retrospective Systematic Analysis of Two Large Double-Blind 6-Month Trials
07:00 AM - 10:00 AM	Abstract	059 - Frequency of Impulse Control Disorders in Patients with Restless Legs Syndrome Treated with Dopaminergic Agents
07:00 AM - 10:00 AM	Abstract	060 - Rotigotine Transdermal System in the Treatment of Idiopathic Restless Legs Syndrome: Combined Results from Two Double-Blind, Placebo-Controlled, Multicenter Studies in Europe and the US
07:00 AM - 10:00 AM	Abstract	061 - Error Monitoring Is Impaired in Obstructive Sleep Apnea
07:00 AM - 10:00 AM	Abstract	062 - Patients at High Risk for Obstructive Sleep Apnea Identified Using the Berlin Sleep Questionnaire Have Worse Functional Outcomes Following a Stroke
07:00 AM - 10:00 AM	Abstract	063 - Association of Periodic Limb Movements without Restless Legs and Cardiovascular Disease
07:00 AM - 10:00 AM	Abstract	064 - Developing and Validating a Patient-Reported Post-Sleep Diary for Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	065 - Efficacy, Tolerability, and Compliance of CPAP Therapy for Obstructive Sleep Apnea in Patients with Mild Cognitive Impairment or Alzheimer's Disease
07:00 AM - 10:00 AM	Abstract	066 - Clinical Usefulness of Sleep Questionnaires in Patients with Obstructive Sleep Apnea Syndrome
07:00 AM - 10:00 AM	Abstract	067 - Prevalence of Restless Legs Syndrome in Patients in Hemodialysis Compared with Peritoneal Dialysis
07:00 AM - 10:00 AM	Abstract	068 - Validation of the Post-Sleep Questionnaire (PSQ) for Assessment of Sleep in Subjects with Restless Legs Syndrome (RLS)
07:00 AM - 10:00 AM	Abstract	069 - What Is Quality of Life for Persons with Restless Legs Syndrome?
07:00 AM - 10:00 AM	Abstract	070 - Self-Report of Restlessness Is Not Enough: Exclusion of Secondary Causes of RLS in Utah Kindreds and Search for Genetic Linkage to Published Loci
07:00 AM - 10:00 AM	Abstract	071 - Motor Planning and Disease Severity Impact Ambulatory Behavior in Parkinson's Disease
07:00 AM - 10:00 AM	Abstract	072 - DJ-1 Expression Modulates Astrocyte-Mediated Neuroprotection in a Toxin-Specific Manner
07:00 AM - 10:00 AM	Abstract	073 - Oscillatory Activities Recorded from the Human Pedunculopontine Nucleus Region during Voluntary Movements
07:00 AM - 10:00 AM	Abstract	074 - DOPAL Treated Rat: A New Behavioral Model for Parkinson's Disease
07:00 AM - 10:00 AM	Abstract	075 - Are There Differences in Cerebral White Matter Lesion Burdens between Parkinson's Disease Patients with and without Dementia?
07:00 AM - 10:00 AM	Abstract	076 - Metabolic Profiles of the Striatum and the Nucleus Accumbens Detected by Proton Magnetic Resonance Spectroscopy (1H MRS) In Vivo in a Murin Model of Parkinson's Disease, the MPTP-Intoxicated Mouse, before and after Levodopa Administration
07:00 AM - 10:00 AM	Abstract	077 - CSF from Parkinson's Disease Patients Differentially Affects [alpha]-Synuclein Density and Cell Growth in Microglia Compared to Astrocytes
07:00 AM - 10:00 AM	Abstract	078 - Autophagic Stress: A Key Problem of Autophagy Upregulation
07:00 AM - 10:00 AM	Abstract	079 - Abnormal Metabolic Network Activity during Phenoconversion of Preclinical Huntington's Disease
07:00 AM - 10:00 AM	Abstract	080 - Recessive Mutations in an Ubiquitin-Like Gene Cause a Late-Onset Recessive Cerebellar Ataxia
07:00 AM - 10:00 AM	Abstract	081 - Clinical Efficacy in Focal Dystonia and Overall Tolerability of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins)
07:00 AM - 10:00 AM	Abstract	082 - Temporal Discrimination Thresholds in Adult-Onset Primary Torsion Dystonia - Physiological and Structural Imaging Evidence for an Endophenotype
07:00 AM - 10:00 AM	Abstract	083 - Long Term Efficacy of Deep Brain Stimulation for Dystonia: A Blinded Assessment
07:00 AM - 10:00 AM	Abstract	084 - Sensory Disinhibition in Cervical Dystonia
07:00 AM - 10:00 AM	Abstract	085 - Effect of Spasticity on Physical Function and Health of Nursing Home Residents
07:00 AM - 10:00 AM	Abstract	086 - Long-Term (7-Year) Cervical Dystonia Safety Study with Botulinum Toxin Type B
07:00 AM - 10:00 AM	Abstract	087 - A Profile of Dystonia in Children: Experience from a Pediatric Neurology Center
07:00 AM - 10:00 AM	Abstract	088 - Efficacy and Safety of NT 201 (Neurotoxin Free from Complexing Proteins) in Cervical Dystonia
07:00 AM - 10:00 AM	Abstract	089 - Long-Term Follow-Up of DYT1 Dystonia Patients Treated by Deep Brain Stimulation
07:00 AM - 10:00 AM	Abstract	090 - Levodopa-Induced Dyskinesias in Spinocerebellar Ataxia Type 2
07:00 AM - 10:00 AM	Abstract	091 - Efficacy and Safety of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins) in Blepharospasm
07:00 AM - 10:00 AM	Abstract	092 - Prognostic Value of Sleep Wake Cycle on Video EEG and MRI in Neonates with HIE Treated with Cool Cap
07:00 AM - 10:00 AM	Abstract	093 - Postnatal Period of Intervention of GTA Supplementation Determines the Extent of Phenotypic Improvement in Tremor Rat Model of Canavan Disease
07:00 AM - 10:00 AM	Abstract	094 - Age- and Region-Specific Analysis of Monoaminergic Systems in the Brain of Mecp2-Null Mice Implies the Prefrontal and Motor Cortices in the Earliest Stages of Disease
07:00 AM - 10:00 AM	Abstract	095 - Cerebral Folate Deficiency and Mitochondrial Disease
07:00 AM - 10:00 AM	Abstract	096 - Deep Brain Stimulation in Patients with Dystonic Cerebral Palsy: 6 Month Follow-Up
07:00 AM - 10:00 AM	Abstract	097 - Developmental Expression of Synaptic Vesicle Protein SV2A
07:00 AM - 10:00 AM	Abstract	098 - Clinical Outcomes in Patients with Duchenne Muscular Dystrophy and Role of Multidisciplinary Care
07:00 AM - 10:00 AM	Abstract	099 - Use of Saliva To Monitor Phenobarbital Levels in Neonates: A Pilot Study
07:00 AM - 10:00 AM	Abstract	100 - Metabolic and Neurological Complications of Antipsychotic Therapy in Children with Tourette Syndrome
07:00 AM - 10:00 AM	Abstract	101 - Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	102 - Ethnicity Is a Possible Risk Factor in the Development of Anti-Epileptic Drug Induced Cutaneous Reactions
07:00 AM - 10:00 AM	Abstract	103 - Lateralization of Temporal Lobe Epilepsy with Long-Term Ambulatory Intracranial Monitoring Using the RNS[trade] System
07:00 AM - 10:00 AM	Abstract	104 - Voxel Based Morphometry Reveals Differences in Familial and Sporadic Forms of Refractory MTLE
07:00 AM - 10:00 AM	Abstract	105 - Safety Profile of Levetiracetam Extended Release as Compared to Immediate Release. An Indirect Comparison Using a Meta-Analytic Approach
07:00 AM - 10:00 AM	Abstract	106 - A New Methodology for Predicting Unbound Phenytoin Concentrations in Hypoalbuminemic Patients, a Novel Approach
07:00 AM - 10:00 AM	Abstract	107 - Clinical Profile of Epilepsy and the Cost of Its Treatment in a Tertiary Care Center in India
07:00 AM - 10:00 AM	Abstract	108 - [3H]Levetiracetam Binding to Brain Membranes: A Putative Allosteric Modulator of AMPA Glutamate Receptor Desensitization
07:00 AM - 10:00 AM	Abstract	109 - Cumulative Effect of Vagal Nerve Stimulator in Intractable Seizures Observed over a Period of Three Years
07:00 AM - 10:00 AM	Abstract	110 - Prognostic Importance of Risk Factors for Extratemporal Lobe Epilepsy in Patients Undergoing Surgical Treatment
07:00 AM - 10:00 AM	Abstract	111 - Suboptimal Dialogue around Mood/Behavior and Side Effects of Epilepsy Medications: Results of an Observational Linguistic Study
07:00 AM - 10:00 AM	Abstract	112 - Long-Term Treatment of Partial Epilepsy with Eslicarbazepine Acetate (ESL): Results of a One-Year Open-Label Extension to Study BIA-2093-301
07:00 AM - 10:00 AM	Abstract	113 - Radiosurgery for MTLE: Sparing of Neurocognition, Prediction of Seizure Remission, and Potential Antiepileptic Mechanisms of Dose-Related Peak MRI Effects
07:00 AM - 10:00 AM	Abstract	114 - Postsurgical Outcome of Frontal Lobe Epilepsy. An Unexpected Finding
07:00 AM - 10:00 AM	Abstract	115 - Evaluation of Lacosamide Efficacy in Subjects with Difficult-to-Treat Partial-Onset Seizures across the Dose Range Used in Phase II/III Clinical Trials
07:00 AM - 10:00 AM	Abstract	116 - Empiric Use of Polycitra K[reg] with the Ketogenic Diet Reduces Kidney Stone Incidence
07:00 AM - 10:00 AM	Abstract	117 - An Evaluation of the Efficacy and Safety of Eslicarbazepine Acetate (ESL) as Add-On Treatment in Adults with Refractory Partial-Onset Seizures: BIA-2093 Study
07:00 AM - 10:00 AM	Abstract	118 - Early Onset of Efficacy in the Initial Weeks of Treatment with Lacosamide: A Pooled Analysis of Three Phase II/III Trials
07:00 AM - 10:00 AM	Abstract	119 - Clinical Significance of Persistent Fetal PCA in Epilepsy Surgery Candidates
07:00 AM - 10:00 AM	Abstract	120 - Catamenial Epilepsy Frequency with Various Antiepileptic Drugs
07:00 AM - 10:00 AM	Abstract	121 - Lacosamide Efficacy Is Independent of Concomitant AED(s) Treatment
07:00 AM - 10:00 AM	Abstract	122 - Thrombolysis in Stroke Attributable to Extra- or Intracranial Cerebral Artery Dissection - Swiss Survey of IV Thrombolysis
07:00 AM - 10:00 AM	Abstract	123 - Outcome of Too Mild Stroke Patients Treated with Thrombolysis: Is It Safe and Effective?
07:00 AM - 10:00 AM	Abstract	124 - Barriers to tPA Use for Inpatient Ischemic Strokes
07:00 AM - 10:00 AM	Abstract	125 - Comparison of tPA Treatment between NonHispanic White and Hispanic American Stroke Patients
07:00 AM - 10:00 AM	Abstract	126 - Implant for Perfusion Augmentation Clinical Trial -1 (ImPACT-1). A Safety and Effectiveness Evaluation of the Ischemic Stroke System (ISS*) in the Treatment of Acute Ischemic Stroke - Pilot Study Report
07:00 AM - 10:00 AM	Abstract	127 - Randomized Study of Butylphthalide (NBP) in Treatment of Acute Cerebral Infarction
07:00 AM - 10:00 AM	Abstract	128 - tPA Therapy Following Acute Stroke Increases Plasma MMP-9 Activity out to Twenty Four Hours
07:00 AM - 10:00 AM	Abstract	129 - Intravenous Recombinant Tissue Plasminogen Activator Administered at 3 to 6 Hours Following Onset of Ischemic Stroke Does Not Improve Outcome. A Meta-Analysis
07:00 AM - 10:00 AM	Abstract	130 - Is Estimated Patient Weight Accurate for IV rt-PA Dosing in Acute Stroke?
07:00 AM - 10:00 AM	Abstract	131 - tPA by Telephone: Comparison of Telephonic Versus In-House Parallel Treatment for Two Cohorts
07:00 AM - 10:00 AM	Abstract	132 - Cutaneous Candida Infection after Treatment with Natalizumab
07:00 AM - 10:00 AM	Abstract	133 - HALT MS - Phase II Clinical Trial of High Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Active Relapsing-Remitting Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	134 - Natalizumab Use in Two French Multiple Sclerosis Centers: The Incidence of Hypersensitivity Reactions Based on Premedication Practices
07:00 AM - 10:00 AM	Abstract	135 - Comparison of Two Therapeutic Strategies in Active Relapsing-Remitting MS: Cyclophosphamide as Induction for 12 Months Followed by Interferon Beta Versus Interferon Beta. A 2-Year Randomized Trial
07:00 AM - 10:00 AM	Abstract	136 - Case Report of Recurrent Pericarditis Due to Natalizumab Treatment with Positive Re-Challenging Test
07:00 AM - 10:00 AM	Abstract	137 - Hypereosinophilia under Natalizumab
07:00 AM - 10:00 AM	Abstract	138 - Memantine as a Treatment for Spasticity in Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	139 - Enhancement Volumes in Multiple Sclerosis Patients Randomized to Interferon Beta 1b or Glatiramer Acetate Imaged by Monthly 3 Tesla Brain MRI with Triple Dose Gadolinium
07:00 AM - 10:00 AM	Abstract	140 - B Cell Depletion and Safety of Low Dose Rituximab in Patients with Relapsing Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	141 - A Phase 1 Trial of Probiotic Helminth Ova in Relapsing Remitting Multiple Sclerosis (RRMS)
07:00 AM - 10:00 AM	Abstract	142 - One Year Follow-Up Results from a Phase 2 Trial of the BHT-3009 DNA Vaccine for Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	143 - Two Annual Cycles of Alemtuzumab Yield Durable Treatment Response 24 Months after Last Dose
07:00 AM - 10:00 AM	Abstract	144 - High Bioavailability and Long Half-Life of Oral Fingolimod (FTY720), an Investigational Treatment for Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	145 - Efficacy of a New Formulation of Subcutaneous Interferon Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis: 16-Week Results from a Double-Blind, Placebo-Controlled Study
07:00 AM - 10:00 AM	Abstract	146 - 4-Aminopyridine as a Treatment for Intractable Eructation: The First Case Report
07:00 AM - 10:00 AM	Abstract	147 - Alemtuzumab Immunotherapy of Treatment-Refractory Multiple Sclerosis
07:00 AM - 10:00 AM	Abstract	148 - Efficacy and Tolerability of Pramipexole in Multiple Sclerosis: Treatment for "Rubral Tremor" Related
07:00 AM - 10:00 AM	Abstract	149 - Long-Term Efficacy and Safety of Intense Immunosuppression as First Line Therapy in Clinically Active Relapsing MS: A New Treatment Algorithm
07:00 AM - 10:00 AM	Abstract	150 - Pharmacokinetic Study of Lipoic Acid in Multiple Sclerosis: Comparing Mice and Human Pharmacokinetic Parameters
07:00 AM - 10:00 AM	Abstract	151 - Efficacy and Safety of Natalizumab in Multiple Sclerosis Patients Pretreated with Immunomodulatory and Immunosuppressive Drugs
07:00 AM - 10:00 AM	Abstract	152 - Pregbalin for Treating Paroxysmal Painful Symptoms in Multiple Sclerosis: An Open Label Study
07:00 AM - 10:00 AM	Abstract	153 - Treating MS Relapses at Home. The Combined Experience of 4 French Regional MS Networks (LORSEP, RBN-SEP, SEP-AUvergne and SINDEFI-SEP) for 807 Patients
07:00 AM - 10:00 AM	Abstract	154 - Modifying Therapies Used in Severe First Idiopathic Acute Inflammatory Events within the Central Nervous System
07:00 AM - 10:00 AM	Abstract	155 - Mycophenolate Mofetil in Multiple Sclerosis: A Retrospective Study
07:00 AM - 10:00 AM	Abstract	156 - Moderate Intensity Resistance Training Does Not Significantly Alter Disease Progression in a Representative Group of ALS Patients
07:00 AM - 10:00 AM	Abstract	157 - Safety Profile of Lithium Treatment in Patients with ALS: A Prospective Open-Label and Off-Label Cohort Studies
07:00 AM - 10:00 AM	Abstract	158 - Is Lithium Therapy Safe for ALS Patients?
07:00 AM - 10:00 AM	Abstract	159 - Retrograde Viral Delivery of GDNF and IGF1 Prevents the Development of Late Weakness (Post-Polio Syndrome) in a Mouse Model
07:00 AM - 10:00 AM	Abstract	160 - Minocycline and Verapamil Reduce Riluzole's Effectiveness in a Preclinical Model System of Mechanisms of Sporadic Amyotrophic Lateral Sclerosis (ALS) Pathogenesis
07:00 AM - 10:00 AM	Abstract	161 - A Phase I-II Multicenter Study on G-CSF in ALS: Clinical and Haematological Results
07:00 AM - 10:00 AM	Abstract	163 - Safety and Short Term Effects of Umbilical Cord Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis: Review of Chinese Data
07:00 AM - 10:00 AM	Abstract	164 - A Double-Blind, Placebo-Controlled, Randomized Trial of Growth Hormone as Add-On Therapy to Riluzole in Patients with Amyotrophic Lateral Sclerosis: Preliminary MRS, Hormonal, and Population Analysis
07:00 AM - 10:00 AM	Abstract	165 - Pontobulbar Palsy with Deafness (Brown-Vialetto-Van Laere Syndrome): Treatment and Prognosis in Ten Patients
07:00 AM - 10:00 AM	Abstract	166 - Different Pathologic Features in Neurfilament Light Chain (NEFL) Pro22 Mutation in Charcot-Marie-Tooth Disease
07:00 AM - 10:00 AM	Abstract	168 - Sequence Analysis of the [alpha]-Crystallin Type Heat Shock Protein Gene Family in Motor Neuropathy Patients
07:00 AM - 10:00 AM	Abstract	169 - CIDP Induced by TNF-[alpha] Antagonists in Rheumatoid Arthritis
07:00 AM - 10:00 AM	Abstract	170 - Concomitance of an Inherited and an Acquired Demyelinating Neuropathy in a Young Girl
07:00 AM - 10:00 AM	Abstract	171 - De Novo Amyloid Deposits and Induced Polyneuropathy in FAP Domino Liver Recipients
07:00 AM - 10:00 AM	Abstract	172 - Parent-of-Origin Effect on Penetrance in Transthyretin Related Familial Amyloid Polyneuropathy
07:00 AM - 10:00 AM	Abstract	173 - CMT2A2 with Upper Motor Neuron Signs in a Patient with a Novel De Novo Mutation in MFN2
07:00 AM - 10:00 AM	Abstract	174 - The Clinical Spectrum of X-Linked Charcot-Marie-Tooth Disease in Childhood
07:00 AM - 10:00 AM	Abstract	175 - Novel Giant Axonal Neuropathy Mutation C[rarr]A146{Ala49Glu} Mimicking Chronic Immune Demyelinating Polyradiculoneuropathy

Faculty Disclosures
Arthur S. Walters, MD, FAAN	No disclosure on file
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN	An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Michael Silber, MB, ChB, FAAN	Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Elliot M. Frohman, MD, FAAN	Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Andrew G. Herzog, MD, MSc, FAAN	Dr. Herzog has nothing to disclose.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Virgilio Gerald H. Evidente, MD, FAAN	Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. The institution of Dr. Evidente has received research support from Vima Pharmaceuticals. The institution of Dr. Evidente has received research support from Biohaven.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Wayne A. Hening, MD, PhD	No disclosure on file
Hiroshi Mitsumoto, MD, FAAN	Dr. Mitsumoto has nothing to disclose.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Andres M. Kanner, MD, FAAN	Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Kirk R. Daffner, MD, FAAN	The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
George H. Kraft, MD	No disclosure on file
Douglas M. Turnbull	No disclosure on file
Andres M. Lozano, MD	Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Michael K. Racke, MD	Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Burk Jubelt, MD	No disclosure on file
Amer Alshekhlee, MD	No disclosure on file
Bruce N. Mayes, MD	No disclosure on file
Edward B. Bromfield, MD, FAAN	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Omar A. Khan, MD, PhD	No disclosure on file
Bashar Katirji, MD, FAAN	Dr. Katirji has nothing to disclose.
John O. Fleming, MD	No disclosure on file
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Frank G. Gilliam, MD, MPH	No disclosure on file
John Shoffner IV, MD	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
James L. Frey, MD, FAAN	No disclosure on file
Kenneth D. Laxer, MD, FAAN	Dr. Laxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK Lfe Sciences. Dr. Laxer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
David C. Tong, MD, FAHA	No disclosure on file
Andrew S. Feigin, MD	Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Douglas R. Labar, MD, PhD	No disclosure on file
Donna C. Bergen, MD, FAAN	No disclosure on file
John N. Caviness, MD, FAAN	Dr. Caviness has nothing to disclose.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Eric M. Wassermann, MD	No disclosure on file
Patricia E. Penovich, MD, FAAN	Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to AAN interests or activities.
David Eidelberg, MD, FAAN	Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
Anne Foundas, MD, FAAN	No disclosure on file
Andrew D. Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Howard Fillit, MD	No disclosure on file
Michael C. Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Lifesciences. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SK Lifesciences .
Keith Hyland, PhD	No disclosure on file
William Dillon, MD	No disclosure on file
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Senda Ajroud-Driss, MD, FAAN	Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Revere P. Kinkel, MD, FAAN	Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi.
Lola C. Morgan, MD	Dr. Morgan has nothing to disclose.
Brandy R. Matthews, MD, FAAN	No disclosure on file
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Mark S. Quigg, MD	Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
Myriam Srour, MD, PhD	Dr. Srour has nothing to disclose.
Olaf Stuve, MD, PhD, FAAN	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Gregory L. Holmes, MD	No disclosure on file
Annette M. Langer-Gould, MD, PhD	An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Yuen T. So, MD, PhD, FAAN	No disclosure on file
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Heather S. Anderson, MD, FAAN	No disclosure on file
Andrew D. Barreto, MD	No disclosure on file
Frank Skidmore, MD	No disclosure on file
Hans D. Katzberg, MD, FAAN	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Dimitrios Kapogiannis, MD	The institution of Dr. Kapogiannis has received research support from National Institute on Aging (NIA/NIH).
H. C. Diener, MD, FAAN	Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Patrik L. Michel, MD	The institution of Dr. Michel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Michel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. The institution of Dr. Michel has received research support from Swiss National Science Foundation; Swiss Heart Foundation.
Christina Caon, RN, BS	Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Valeria Drago, MD	No disclosure on file
Muhammad Qureshi, MD	No disclosure on file
Christopher M. Filley, MD, FAAN	Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Erik K. St. Louis, MD	The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Tanis J. Ferman, PhD	Ms. Ferman has nothing to disclose.
Andrei V. Alexandrov, MD	The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Imran I. Ali, MD, FAAN	Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Michael P. Alexander, MD, FAAN	No disclosure on file
Lahar R. Mehta, MD	Dr. Mehta has received personal compensation for serving as an employee of Amylyx Pharmaceuticals.
Eric H. Kossoff, MD	Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia. Dr. Kossoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simply Good Foods. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cambrooke. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care.
Tsutomu Nakada, MD, PhD	No disclosure on file
Ingrid L. Kwee, MD	Dr. Kwee has nothing to disclose.
	No disclosure on file
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Daniel Kantor, MD, FAAN	Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Marc Debouverie, MD	Dr. Debouverie has nothing to disclose.
Pierre Clavelou, MD, PhD	Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Gilles Defer, MD	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Li M. Li, MD	No disclosure on file
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Daniela Galimberti, PhD	No disclosure on file
Chiara Fenoglio, PhD	No disclosure on file
Nereo Bresolin, DR	No disclosure on file
Donald Stuss	No disclosure on file
Fernando Acosta, MD	No disclosure on file
Mya C. Schiess, MD, FAAN	Dr. Schiess has nothing to disclose.
Kevin R. Scott, MD, FAAN	No disclosure on file
Zachary Simmons, MD, FAAN	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Helen E. Stephens	No disclosure on file
Jane S. Paulsen, PhD	Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Matthias Maschke, MD	No disclosure on file
Helene Zephir	Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
David Hess, MD	No disclosure on file
Byung-Ok Choi, MD, PhD	No disclosure on file
James E. Galvin, MD, MPH	Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Flavia Mattioli, MD	Dr. Mattioli has nothing to disclose.
Harry O. Openshaw, MD	No disclosure on file
George J. Hutton, MD, FAAN	Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Philippe Coubes, PhD	No disclosure on file
Ana Laura Cif, MD	No disclosure on file
Lucien Rumbach, MD	No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN	Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union. The institution of Dr. Karageorgiou has received research support from Alzheimer's Association.
Ruggero Capra, MD	Dr. Capra has nothing to disclose.
Claudio Mariani, MD	No disclosure on file
David P. Roeltgen, MD, FAAN	No disclosure on file
Judith L. Ross, MD	No disclosure on file
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Ronald M. Lazar, PhD, FAHA, FAAN	Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Joanne Festa, PhD	No disclosure on file
Franck Durif, MD, PhD	No disclosure on file
Gabriele Mora, MD	Dr. Mora has nothing to disclose.
Vincenzo Silani, MD, FAAN	Dr. Silani has nothing to disclose.
Luca Durelli, MD	No disclosure on file
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Raoul Morales, MD	No disclosure on file
William Camu, MD	No disclosure on file
Steven R. Schwid, MD, FAAN	No disclosure on file
Richard Walsh, MD	Dr. Walsh has nothing to disclose.
Rafael G. Blesa, MD	Dr. Blesa has nothing to disclose.
Pietro Tonali, MD	No disclosure on file
Frederic Blanc	No disclosure on file
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Giuseppe Magnani	Giuseppe Magnani has nothing to disclose.
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Sandrine Wiertlewski	No disclosure on file
David Laplaud	No disclosure on file
Stuart D. Cook, MD, FAAN	No disclosure on file
Alessandro Filla, MD, FAAN	No disclosure on file
Giuseppe De Michele, MD	No disclosure on file
Arnaud Lacour	No disclosure on file
Netta Levin, MD, PhD	Dr. Levin has nothing to disclose.
Monique M. Ryan, MD	Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen . The institution of Dr. Ryan has received research support from Save our Sons Muscular Dystrophy . The institution of Dr. Ryan has received research support from Muscular Dystrophy Australia. Dr. Ryan has received publishing royalties from a publication relating to health care.
Garth Nicholson, PhD	No disclosure on file
Ja-Seong Koo, MD	No disclosure on file
Jong-Moo Park, MD	No disclosure on file
Ohyun Kwon	No disclosure on file
Byung-kun Kim, MD	Dr. Kim has nothing to disclose.
Alexandros L. Georgiadis, MD	No disclosure on file
Juan J. Figueroa, MD	No disclosure on file
Sun-Ah Choi, MD, PhD	No disclosure on file
Fouzia Siddiqui, MD, FAAN	No disclosure on file
Fen Bao	Fen Bao has nothing to disclose.
James D. Bowen, MD	Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Didier Ferriby, MD	No disclosure on file
Olivier Outteryck	Olivier Outteryck has nothing to disclose.
Alexandros C. Tselis, MD, PhD	No disclosure on file
Iscia Lopes-Cendes, MD, PhD	No disclosure on file
Leonard Verhagen Metman, MD, PhD	Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Claudia V. Maurer-Morelli, PhD	No disclosure on file
Holly A. Shill, MD, FAAN	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Jean-Pierre Bouchard, MD, FAAN	No disclosure on file
David D. Adams	David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Violaine Plante-Bordeneuve, MD	Dr. Plante-Bordeneuve has nothing to disclose.
Joseph Hentz	No disclosure on file
Giuliano Binetti, MD	No disclosure on file
Dheeraj Khurana, MD	Dr. Khurana has nothing to disclose.
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Glenn E. Smith, MD, PhD	No disclosure on file
Vijay Dhawan, PhD	No disclosure on file
Yilong Ma, PhD	The institution of Dr. Ma has received research support from AskBio. The institution of Dr. Ma has received research support from Aspen Neuroscience . The institution of Dr. Ma has received research support from Blue Rock . The institution of Dr. Ma has received research support from Bayer.
Patricio F. Reyes, MD, FAAN	No disclosure on file
Mirjam Korporal-Kuhnke, MD	Dr. Korporal-Kuhnke has nothing to disclose.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Peter B. Forgacs, MD	Dr. Forgacs has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Forgacs has or had stock in Xenon Pharmaneuticals.
Jeffrey A. Switzer, DO, FAAN	Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Expert Speaker on a panel with Genentech. Dr. Switzer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with SAA Alumni Association.
Pradeep K. Sahota, MD, FAAN	The institution of Dr. Sahota has received research support from VA Merit award.
William J. Burke, MD, PhD, FAAN	No disclosure on file
Vijay B. Kumar	No disclosure on file
W. Michael Panneton, PhD	No disclosure on file
Gyula Acsadi, MD, FAAN	Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Byung-Jo Kim	No disclosure on file
Agnes Jani-Acsadi, MD	No disclosure on file
Elena Moro, MD, FAAN	Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Bruno Brochet, MD, FEAN	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Ki H. Cho, MD, PhD	No disclosure on file
Myeong-Kyu Kim	No disclosure on file
Byeong-chae Kim, MD, PhD	No disclosure on file
Seung-Han Lee, MD, PhD	Dr. Lee has nothing to disclose.
Man Seok Park, MD, PhD	No disclosure on file
Kee Duk Park, MD	No disclosure on file
Kyoung-Gyu Choi	No disclosure on file
Claudia Trenkwalder, MD	Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Jeffery Gunter	The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Richard P. Allen, PhD	No disclosure on file
David G. Munoz, MD	No disclosure on file
Perry K. Richardson, MD	Dr. Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedForce.
Njide Okubadejo, MD, FAAN	The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Mithri R. Junna, MD	Dr. Junna has nothing to disclose.
Daniel L. Labovitz, MD	An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
Peter J. Dyck, MD, FAAN	Dr. Dyck has nothing to disclose.
Clete A. Kushida, MD, PhD	Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Michael McDermott	No disclosure on file
Victoria Lawson, MD, FAAN	Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Diego Cadavid, MD, FAAN	Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Leo Wolansky, MD	The institution of Dr. Wolansky has received research support from Guerbet.
Barbara E. Tettenborn, MD	No disclosure on file
Robert E. Chen, MD, MBBChir	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Frances E. Jensen, MD, FAAN	Dr. Jensen has nothing to disclose.
Maria Teresa Gomez-Isla, MD	No disclosure on file
Heinrich P. Mattle, MD	No disclosure on file
Constantine Lyketsos	Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
Bill Nikolov	No disclosure on file
Kristen Fowler	No disclosure on file
Aleksandar Videnovic, MD, MSc, FAAN	Dr. Videnovic has nothing to disclose.
Daniel Lee, MD, FAAN	No disclosure on file
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Wenbo Zhang, MD, PhD	No disclosure on file
Deanna Dickens, MD	No disclosure on file
Gail L. Risse, PhD	No disclosure on file
Nancy L. Kuntz, MD, FAAN	Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Paola Pergami, MD, PhD	No disclosure on file
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Farrukh S. Khan, MD, MBBS	No disclosure on file
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Lynn Stazzone, RN	Ms. Stazzone has nothing to disclose.
Chris Tang, MD	No disclosure on file
Teepu Siddique, MD, FAAN	No disclosure on file
Stephen N. Scelsa, MD	No disclosure on file
Patricio S. Espinosa, MD, MPH, FAAN	Dr. Espinosa has nothing to disclose.
Daniel M. Canafax, PharmD	No disclosure on file
Aaron Ellenbogen, DO	Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Sungho K. Cho, MD	Dr. Cho has nothing to disclose.
Lawrence Steinman, MD, FAAN	Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Wilmer Hale Cutler Pickering. Dr. Steinman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Hideki Garren, MD, PhD	Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya.
Naim I. Haddad, MD, FAAN	Dr. Haddad has nothing to disclose.
Ronald B. Ziman, MD, FACP, FAAN	No disclosure on file
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Venkata S. Dandamudi, MD	No disclosure on file
Joyce A. Cramer	No disclosure on file
Luisa Alves	No disclosure on file
Jeffrey C. Looi, MD	No disclosure on file
nobl barazangi, MD, PhD	Dr. Barazangi has nothing to disclose.
Vijay K. Sharma, MD	No disclosure on file
Elio A. Scarpini, MD	No disclosure on file
Debomoy K. Lahiri, PhD	No disclosure on file
John M. Olichney, MD	No disclosure on file
Robert J. Schwartzman, MD	No disclosure on file
Randi Hagerman	Randi Hagerman has received publishing royalties from a publication relating to health care.
Jean Mathieu, MD	Dr. Mathieu has nothing to disclose.
Mark Obermann, MD, FAAN	No disclosure on file
Thamer S. Alkhairallah, MD, MBBS	No disclosure on file
Alain Creange	Alain Creange has nothing to disclose.
Peter J. Koudstaal, MD	No disclosure on file
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
J. Douglas Miles, MD, PhD, FAAN	Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Brian J. Murray, MD, FAAN	The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Toshiki Takenouchi, MD	No disclosure on file
Victoria S. Pelak, MD, FAAN	Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.
Bernard Brais, MD	Dr. Brais has nothing to disclose.
Mark Guttman, MD	No disclosure on file
Martina Vendrame, MD PhD	Dr. Vendrame has nothing to disclose.
Latha Ganti, MD, MS, MBA, FACEP	Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Benito P. Damasceno, MD, PhD	No disclosure on file
Barbara A. Dworetzky, MD, FAAN	Dr. Dworetzky has received publishing royalties from a publication relating to health care.
Jyoti Pillai, MD, MBBS, MRCP, FAAN	Dr. Pillai has a non-compensated relationship as a President with Pennsylvania Neurological Association that is relevant to AAN interests or activities.
Elayna Rubens, MD	No disclosure on file
Jinsy Andrews, MD, FAAN	Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Meyer Squibb. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from ALS Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Michael I. Shevell, MD, FAAN	Dr. Shevell has nothing to disclose.
Mario Zappia, MD	No disclosure on file
Barry Kosofsky, MD	No disclosure on file
Philippe A. Lyrer, MD	No disclosure on file
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
David J. Libon, PhD	No disclosure on file
Bashir S. Shihabuddin, MD	No disclosure on file
Jong W. Lee, MD, PhD	The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from UCB. Dr. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Contract work with Teladoc.
Fiona M. Molloy, MD	Dr. Molloy has nothing to disclose.
Laura A. Kalayjian, MD	The institution of Dr. Kalayjian has received research support from NIH.
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Jean C. Ouallet	Jean C. Ouallet has nothing to disclose.
Amilton A. Barreira, MD	No disclosure on file
Debabrata Ghosh, MD	No disclosure on file
Jeffrey M. Burns, MD	Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Pamela Doty, PhD	No disclosure on file
Sarah Benisty, MD	No disclosure on file
Dan Bell	No disclosure on file
Onofre Combarros Pascual	No disclosure on file
Joseph D. Burns, MD	Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Irene J. Oh, MD	No disclosure on file
Lynne Shinto, ND	No disclosure on file
Scott McGinnis, MD	Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Christian Denier	No disclosure on file
Jose Ignacio Mateo Fernandez	No disclosure on file
Jon Infante Ceberio	No disclosure on file
Jai Perumal, MD	Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for T G therapeutics. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono.
David Gloss, MD, FAAN	Dr. Gloss has received personal compensation in the range of $500-$4,999 for serving as a DUR Board Member with WV Dept of Health and Human Services.
Naila Makhani, MD	Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Stefano F. Cappa, MD	Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier. The institution of Dr. Cappa has received research support from Italian Minsitry of Health.
Michael Calloway	No disclosure on file
Hyemi Chong	No disclosure on file
Marie-Josee Dicaire	Marie-Josee Dicaire has nothing to disclose.
Sailaja Enduri, MD	No disclosure on file
JaNean Engelstad	JaNean Engelstad has nothing to disclose.
Georgios Tsivgoulis, MD, FAAN	Dr. Tsivgoulis has nothing to disclose.
Nam Hee Kim, MD	No disclosure on file
Clement Hamani	No disclosure on file
Florian Hatz, MD	No disclosure on file
Mohammad Ikram	The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Jung-Ju Lee, MD, PhD	No disclosure on file
Salvatore Lo Fermo	No disclosure on file
Pierre Lozeron	No disclosure on file
Mi Sun Oh	No disclosure on file
James Rubenstein	No disclosure on file
Jeffrey Mock II, PhD	No disclosure on file
Vanessa Marques	No disclosure on file
Wilson Marques, Jr., MD	Dr. Marques has nothing to disclose.
Eloy Rodriguez-Rodriguez	Eloy Rodriguez-Rodriguez has nothing to disclose.
Andrea L. Rosso, MPH	No disclosure on file
Frederic Taithe	No disclosure on file
Mohamed Teleb, MD	Dr. Teleb has nothing to disclose.
Isabelle Thiffault, PhD	No disclosure on file
Eppie Yiu, MD	The institution of Dr. Yiu has received research support from Biogen. The institution of Dr. Yiu has received research support from Roche . The institution of Dr. Yiu has received research support from PTC. The institution of Dr. Yiu has received research support from Pfizer .
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Lana Boursoulian, MD	No disclosure on file
W. C. LaFrance, Jr., MD, MPH, FAAN	Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Vijayshree Yadav, MD, FAAN	Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Gail H. Marracci, PhD	No disclosure on file
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
David M. Labiner, MD	The institution of Dr. Labiner has received research support from CDC.
Felix Fluri, MD	No disclosure on file
Joseph M. Ferrara, MD, FAAN	No disclosure on file
Ben Schmand, PhD	Dr. Schmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Philips. Dr. Schmand has received publishing royalties from a publication relating to health care.
Carlos A. Guerreiro, MD, FAAN	No disclosure on file
Fatema J. Serajee, MBBS	Dr. Serajee has nothing to disclose.
Ahm M. Huq, MBBS, PhD	Dr. Huq has nothing to disclose.
Ralf Kohnen, PhD, ScD	No disclosure on file
Luigi Ferini-Strambi, MD	Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Ferini-Strambi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for idorsia. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bruno Farmaceutici. Dr. Ferini-Strambi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Sleep Medicine.
Robbie Buechler, MD, PhD	No disclosure on file
Jennifer R. Molano, MD, FAAN	Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Maja Tippmann-Peikert, MD	Dr. Tippmann-Peikert has nothing to disclose.
Ajit K. Roy, MD	No disclosure on file
Jason R. Cornelius, MD	No disclosure on file
I-Hweii A. Chen, MD, PhD, FAAN	The institution of Dr. Chen has received research support from Healey Center at Massachusetts General Hospital. The institution of Dr. Chen has received research support from General Hospital Corporation. The institution of Dr. Chen has received research support from Argenx.
Augusto A. Miravalle, MD, FAAN	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Laure Michel	No disclosure on file
B. L. Peterlin, DO	Dr. Peterlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Paulo Bugalho	No disclosure on file
Ya-Ping Yang	No disclosure on file
Chunfeng Liu	No disclosure on file
Mary Scaduto	No disclosure on file
Konner Hamous	No disclosure on file
Gabriele Siciliano	Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Luiz E. Betting	Dr. Betting has nothing to disclose.
Amanda Jagolino-Cole, MD, FAAN	Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� - Neurology Clinical Practice Journal. .
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Massimo Corbo	No disclosure on file
Claudio Solaro, MD	No disclosure on file
Abdul Malik, MD, FAAN	No disclosure on file
Gianna Carla Riccitelli	No disclosure on file
Mario Quarantelli, MD	No disclosure on file
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
William Birmingham	No disclosure on file
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Paolo A. Muraro, MD, PhD	No disclosure on file
Carlo Rinaldi, MD, PhD	No disclosure on file
David Bradley, MD	Dr. Bradley has nothing to disclose.
Martijn Muller, PhD	No disclosure on file
Juliana Setyawan, PharmD, MS	No disclosure on file
Ningshan Wang, MD, PhD	Dr. Wang has nothing to disclose.
Egon Stenager, MD	No disclosure on file
Chikkathur N. Madhavarao, PhD	No disclosure on file
Virend Somers	Virend Somers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Virend Somers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axome. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ApniMed. The institution of Virend Somers has received research support from National Institutes Health.
Sinead Jordan	Sinead Jordan has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Idec.
Eric Tsang	No disclosure on file
Raffaella Migliaccio	Raffaella Migliaccio has nothing to disclose.
David Arkadir, MD	No disclosure on file
Imen Kacem, MD	Dr. Kacem has nothing to disclose.
Jana Godau, MD	No disclosure on file
Izad-Yar D. Rasheed, MD	Dr. Rasheed has nothing to disclose.
Marjorie Bunch, MD	Dr. Bunch has a non-compensated relationship as a Professional Advisory Committee with Epilepsy Foundation that is relevant to AAN interests or activities.
Elias Abou-Zeid, MD	No disclosure on file
Saleh Al Deeb, MD	No disclosure on file
Daniel Alcolea Rodriguez	Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fujirebio Europe. Daniel Alcolea Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Daniel Alcolea Rodriguez has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Nutricia. The institution of Daniel Alcolea Rodriguez has received research support from Fujirebio - Europe. Daniel Alcolea Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Fusun Alehan, MD	No disclosure on file
Tariq B. Alfahad, MD	No disclosure on file
Mohammad A. Al-Muhaizea, MD	Dr. Al-Muhaizea has nothing to disclose.
Hardik Amin, MD	No disclosure on file
Miya Asato, MD, FAAN	Dr. Asato has nothing to disclose.
Peggy Auinger	Ms. Auinger has nothing to disclose.
Kristen Babinski, MD	Dr. Babinski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Babinski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer, P.C..
Antoaneta J. Balabanov, MD	Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen.
Ronald Barrett	No disclosure on file
Jean M. Bidlack, PhD	No disclosure on file
Laurie Bliss	No disclosure on file
Andrew S. Blum, MD, PhD, FAAN	The institution of Dr. Blum has received research support from DOD-Ocean State Research Institute, Inc/NIH. The institution of Dr. Blum has received research support from NSF - SBIR. The institution of Dr. Blum has received research support from Alpert Medical School. The institution of Dr. Blum has received research support from Alpert Medical School. Dr. Blum has received publishing royalties from a publication relating to health care. Dr. Blum has received personal compensation in the range of $500-$4,999 for serving as a Medical Director for Ambulatory Video-EEG LTM services, on behalf of Brown Neurology with United Sleep Diagnostics.
Saeed A. Bohlega, MD	No disclosure on file
Eric Brahin, MD	No disclosure on file
Donna Broshek	Donna Broshek has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Sports Neuropsychology Society.
Matthew P. Bussa, MPH	No disclosure on file
Michael Carrithers, MD, PhD	The institution of Dr. Carrithers has received research support from Biogen.
Edward F. Chang, MD	No disclosure on file
Carine Chassain, PhD	No disclosure on file
Alice Chen-Plotkin, MD	Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Jojy V. Cheriyan, MD	No disclosure on file
Seongmin Choi, MD	No disclosure on file
Mickael Cohen	No disclosure on file
Joanna A. Cooper, MD	No disclosure on file
Emanuele D'Amico	Emanuele D'Amico has nothing to disclose.
Manuela De Stefano	No disclosure on file
Mark Decerbo, PharmD	No disclosure on file
Daria Dinacci	No disclosure on file
Jenna B. Dionisio	No disclosure on file
Sandra Donkervoort	Ms. Donkervoort has nothing to disclose.
Sara El Alaoui	No disclosure on file
Murray Engel, MD, FAAN	No disclosure on file
Elizabeth R. Fagan, MBBS	No disclosure on file
Faisal Fecto, MD, PhD	The institution of Dr. Fecto has received research support from NINDS.
Paola Fortis	No disclosure on file
Diego Garcia-Borreguero, MD	No disclosure on file
Jaime F. Godoy, MD	No disclosure on file
Victoria Gonzalez, MD	No disclosure on file
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Susanne Grafe, MD	No disclosure on file
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Patricia R. Grossman	No disclosure on file
Alla Borisovna Guekht, PhD	The institution of Prof. Guekht has received research support from Russian Science Foundation .
Khatuna Gurgenashvili, MD, FAAN	Dr. Gurgenashvili has nothing to disclose.
Stefan Gutwinski	No disclosure on file
Judith Haas, MD	No disclosure on file
Anhar Hassan, MBBCH, FRACP, FRCPI, FAAN	The institution of Dr. Hassan has received research support from Intrabio . Dr. Hassan has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Korean Movement Disorders Society.
Christianne N. Heck, MD	Dr. Heck has nothing to disclose.
Sandra L. Helmers, MD, FAAN	No disclosure on file
Richelle A. Hemendinger, PhD	No disclosure on file
Christina Hill-Zabala, PharmD	No disclosure on file
David A. Hinkle, MD, PhD	No disclosure on file
Hans-Joerg Hungerbuehler, MD	No disclosure on file
Heli Hunter, NP	No disclosure on file
Aamir Hussain, MD	No disclosure on file
Siobhan Hutchinson, MD	Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Lauren Hyland	No disclosure on file
Neeraj Jain, MD	No disclosure on file
Meghan Jeffres	No disclosure on file
Hyun-Jung Jung, MD	No disclosure on file
Anahid Kabasakalian, MD	No disclosure on file
Atul Kalanuria, MD	Dr. Kalanuria has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for American Medical Experts. Dr. Kalanuria has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expertiq.
Padmaja N. Kandula, MD	Dr. Kandula has nothing to disclose.
Sucjoo Kim, MD	No disclosure on file
David King-Stephens, MD	Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Joo Y. Kwon, MD	No disclosure on file
Charles M. Lourenco, MD, PhD	No disclosure on file
Max R. Lowden, MD, FAAN	Dr. Lowden has nothing to disclose.
Christopher C. Luzzio, MD	No disclosure on file
Daniel J. MacGowan, MD, FAAN	No disclosure on file
Patricia Maciel, MD	No disclosure on file
Samuel J. Maiser, MD	Dr. Maiser has nothing to disclose.
Meghna Mansukhani	No disclosure on file
Warren Marks, MD	No disclosure on file
Angela Marsili	Angela Marsili has nothing to disclose.
Letizia Mazzini	No disclosure on file
Melanie McNally, MD	No disclosure on file
Shima Mehrabian	No disclosure on file
Aurelio Mendez-Dominguez, MD	Dr. Mendez-Dominguez has nothing to disclose.
Lisa R. Merlin, MD, FAAN	Dr. Merlin has nothing to disclose.
Silvia Messina	No disclosure on file
Tai-Seung Nam, MD	No disclosure on file
Marc Narayansingh, MD	No disclosure on file
Ugo Nocentini	No disclosure on file
Elias M. Ntsoane, MD	No disclosure on file
Michael S. Oh, MD	No disclosure on file
Pedro S. Oliveira, MD	No disclosure on file
Christian Otoul	No disclosure on file
Michael J. Painter, MD, FAAN	No disclosure on file
Jamie Pak, BA	No disclosure on file
Vincenzo Palma	No disclosure on file
Gunjan Parikh, MD	The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
Ji-Young Park, MD	No disclosure on file
A T. Perkins, MD, PhD	No disclosure on file
J S. Poceta, MD	No disclosure on file
Kathleen Poston, MD, FAAN	Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Samuel J. Potolicchio, Jr., MD	No disclosure on file
Joanne Quan, MD	No disclosure on file
Florent Richy, PhD	No disclosure on file
Ronald G. Riechers II, MD	No disclosure on file
Jose Luis Rodriguez-Valdez, PhD	No disclosure on file
Jack C. Rose, MD	No disclosure on file
Marvin A. Rossi, MD, PhD	Dr. Rossi has nothing to disclose.
G. David Rudd, PharmD, MS	No disclosure on file
Nirav Sanghani, MBBS	Dr. Sanghani has nothing to disclose.
Robert Schmouder	No disclosure on file
Guido Schwegler, MD	No disclosure on file
Tamara Scott	No disclosure on file
Arunkumar B. Shah, MD, DM	No disclosure on file
Jisoo S. Shin, MD	No disclosure on file
Elisabeth Simard-Tremblay, MD	No disclosure on file
Nancy Slocumb	No disclosure on file
Sarah Smithson	No disclosure on file
Patricio Soares-da-Silva	Patricio Soares-da-Silva has received personal compensation for serving as an employee of Bial - Portela & Cª S.A.. Patricio Soares-da-Silva has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Bial - Portela & Cª S.A..
Michael A. Stein, MD	No disclosure on file
Stephanie Syc-Mazurek, MD, PhD	Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Charles A. Szabo, MD, FAAN	Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Delia M. Talos, MD	No disclosure on file
Paolo Tanganelli	No disclosure on file
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Philippe Temperli, MD	No disclosure on file
Jane Tiller	No disclosure on file
Latchezar D. Traykov, MD	No disclosure on file
Brian S. Tseng, MD, PhD	No disclosure on file
Mark Versavel, MD, PhD	An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
Mariann M. Ward, NP, MS	No disclosure on file
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Tzu-Ching Wu, MD	Dr. Wu has nothing to disclose.
Soo Y. You, MD	No disclosure on file
James M. Youakim, MD	Dr. Youakim has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Youakim has stock in Acadia Pharmaceuticals.
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Isa A. Al-Sharoqi, MD, MRCP	No disclosure on file
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Valerie Jaillon Riviere, MD	No disclosure on file
Alberto Lleo, MD	Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Lleo has received research support from Instituto de Salud Carlos III. The institution of Dr. Lleo has received research support from Generalitat de Calalunya (PERIS). The institution of Dr. Lleo has received research support from BBVA Foundation. The institution of Dr. Lleo has received research support from La Caixa Foundation. Dr. Lleo has received intellectual property interests from a discovery or technology relating to health care.
Felix A. Mueller, MD	No disclosure on file
Laura Molina Porcel, MD	No disclosure on file
Didier Deffond	No disclosure on file
Jan L. De Bleecker, MD, PhD, FAAN	Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Eric Lancaster, MD, PhD	Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Daniel Martinez-Ramirez, MD	Dr. Martinez-Ramirez has nothing to disclose.
Dominick J. McCabe, MD, PhD	No disclosure on file
Janice M. Redmond, MD	Dr. Redmond has nothing to disclose.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Maria E. Baldwin, MD	Dr. Baldwin has nothing to disclose.
Mario Habek, MD	Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Laxmi P. Dhakal, MD	No disclosure on file
Bryan Smith, MD	Dr. Smith has nothing to disclose.
Timothy F. Cloughesy, MD	Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vida Ventures. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lista Therapeutics. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stemline. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sonalasense. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jubilant. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gan & Lee. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainstorm. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Cloughesy has received personal compensation in the range of $0-$499 for serving as a Consultant for Inovio. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DNATrix. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tyme. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kintara. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Katmai. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Break Through Cancer. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kintara. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Katmai. Dr. Cloughesy has stock in Katmai. Dr. Cloughesy has stock in Chimerix. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care.
Anthony Behin	No disclosure on file
Eric Leguern, Sr., MD, PhD	No disclosure on file
Iva Stankovic	Iva Stankovic has nothing to disclose.
Patricia G. Barbalho, PhD	No disclosure on file
Rezvan Rostami, MD	No disclosure on file
Valerie Rundle-Gonzalez, MD	No disclosure on file
Wissam G. Deeb, MD, FAAN	Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to AAN interests or activities.
Ahmad Abulaban, MD, FAAN	Dr. Abulaban has nothing to disclose.
Thais Armangue, MD	Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
Brion D. Reichler, MD	No disclosure on file
Eugene Redmond, MD	No disclosure on file
David A. Cottrell, MD, PhD	No disclosure on file
Leendert H. Visser, MD	No disclosure on file
Victor H. Gonzalez-Montoya, MD	No disclosure on file
Zhi-Jian Chen, MD	Dr. Chen has nothing to disclose.
Lauren M. Massimo, PhD	No disclosure on file
Ali Saeed, MD	No disclosure on file
Priya Dhawan, MD	Dr. Dhawan has nothing to disclose.
Patricio Chrem Mendez, MD	Dr. Chrem Mendez has nothing to disclose.
Mohamad Ezzeldin, MD	Dr. Ezzeldin has nothing to disclose.
Gloria Dalla Costa	No disclosure on file
Kim Yen Thi Vu, LMSW	No disclosure on file
Leslie Guthery	Leslie Guthery has nothing to disclose.
Luisa Vuolo	No disclosure on file
Pawel Tacik, MD	The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, Anavex Life Sciences Corp. The institution of Dr. Tacik has received research support from Merz Therapeutics, Ipsen Pharma, AbbVie Germany, Boston Scientific Medical Technology, Medtronic. Dr. Tacik has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Merz Therapeutics, Ipsen Pharma.
Sirwan K. Darweesh, MD, PhD	No disclosure on file
Stephan Goedee, MD	No disclosure on file
Tiffany K. Grider, MS, CGC	Ms. Grider has received personal compensation in the range of $0-$499 for serving as a author of educational material with Muscle Dystrophy Association.
Christina Wilson, MD, FAAN	Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH Stroke Net. The institution of an immediate family member of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Bristol-Myers Squibb and BMS-Pfizer/Roche Diagnostics . An immediate family member of Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care. Dr. Wilson has received publishing royalties from a publication relating to health care.
Ersin Tan, MD	Dr. Tan has nothing to disclose.
Ana M. Malmierca, MD	No disclosure on file
Santiago Bestoso, MD	No disclosure on file
Paola Perini	No disclosure on file
Fahad S. Al-Ajlan, MD	Dr. Al-Ajlan has nothing to disclose.
Reversa R. Mills-Joseph, MD	Dr. Mills has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin, Inc. Dr. Mills has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Marina B. Rubin, MD	No disclosure on file
Ainie Soetanto, MD	No disclosure on file
Nancy Ann Oberheim Bush, MD, PhD	Dr. Oberheim Bush has nothing to disclose.
Niravkumar Barot, MD	Dr. Barot has nothing to disclose.
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Sandeep Dhanyamraju, MD	No disclosure on file
Bernard P. Chan, MD	The institution of Dr. Chan has received research support from National University Hospital, Singapore.
Vladimir Evilevitch	No disclosure on file
Alfonso Alejandra	No disclosure on file
Alex Hillyer	No disclosure on file
Brandi L. Vollmer, MPH	Ms. Vollmer has nothing to disclose.
Yi Shiau Ng	No disclosure on file
Jahir Miranda Acuña	No disclosure on file
Roberto Erro	No disclosure on file
Jean Levi Ribeiro De Paiva	No disclosure on file
Anuschka Grobelny	No disclosure on file
Shihui Xing, MD, PhD	No disclosure on file
John B. Falconer, MD	No disclosure on file
Jonathan Y. Streifler, MD	No disclosure on file
Louisa Kalsner, MD	No disclosure on file
Eugenia Marzo	No disclosure on file
Janice M. Buelow, PhD, RN	No disclosure on file
Franziska Di Pauli	Franziska Di Pauli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for horizon. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Franziska Di Pauli has received research support from Roche.
Melvin Berger, MD, PhD	No disclosure on file
Bharatendu Chandra, MD	Dr. Chandra has received intellectual property interests from a discovery or technology relating to health care.
Yara Mikhaeil-Demo, MD	Dr. Mikhaeil-Demo has nothing to disclose.
Jennifer M. Martinez-Thompson, MD, FAAN	Dr. Martinez-Thompson has nothing to disclose.
Julian C. Duda, MD	No disclosure on file
Judy H. Ch'ang, MD	Dr. Ch'ang has nothing to disclose.
Purwa Joshi, MBBS	No disclosure on file
Fiona Thomas	No disclosure on file
Alessandra Protti	No disclosure on file
Kelianne Cummings	No disclosure on file
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Naila Alakbarova, MD	No disclosure on file
Noa Bregman	Noa Bregman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. The institution of Noa Bregman has received research support from Ionis pharmaceuticals.
Andreas Dammann Andersen	No disclosure on file
Ximena Gamboa, MD	Dr. Gamboa has nothing to disclose.
Rens Hanewinckel, MD, PhD	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��